USANA Health Sciences Reports Second Quarter Net Sales of $238 Million and Diluted EPS of $0.89
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
USANA Health Sciences (USNA) Tops Q2 EPS by 19c
July 25, 2023 4:07 PM EDTUSANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.89, $0.19 better than the analyst estimate of $0.70. Revenue for the quarter came in at $238 million versus the consensus estimate of $231.14 million.
GUIDANCE:
USANA Health Sciences sees FY2023 EPS of $2.65-$3.30, versus the... More
